Use of phosphate binder in predialysis patients

Masatomo Taniguchi

Research output: Contribution to journalReview article

Abstract

Recently, it is evident that sevelamer hydrochloride is superior to calcium carbonate in the anti-phosphorus therapy for the dialysis patients, from the viewpoints of vascular calcification and mortality. The efficacy of sevelamer hydrochloride was also suggested in predialysis patients. Although, in Japan, calcium carbonate, but not sevelamer, is only approved to the treatment in predialysis patients. It should be discussed about lanthanum carbonate. In this review, the management of phosphorus and the administration of phosphate binder in predialysis patients are extrapolated.

Original languageEnglish (US)
Pages (from-to)229-235
Number of pages7
JournalClinical calcium
Volume19
Issue number2
StatePublished - Feb 2009

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Taniguchi, M. (2009). Use of phosphate binder in predialysis patients. Clinical calcium, 19(2), 229-235.